rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TPST
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D Candidate
      Nov 11Yahoo FinanceTPST
      12 Health Care Stocks Moving In Wednesday's After-Market Session
      Oct 21BenzingaTENXTPST
      Tempest Therapeutics adjourns special meeting, sets reconvened date for November
      Oct 20Investing.comTPST
      Tempest Therapeutics Adds Veteran Executive to Board

      Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

      Oct 20The Globe and MailTPST
      Tempest Therapeutics appoints Nancy Freda-Smith to board
      Sep 23Investing.comTPST
      Tempest Therapeutics (TPST) Stock Surges Wednesday: What's Driving the Action?
      Sep 16BenzingaTPST
      12 Health Care Stocks Moving In Wednesday's Pre-Market Session
      Sep 16BenzingaTPST
      Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
      Sep 16BenzingaTPST
      Top Premarket Gainers
      Sep 16Yahoo FinanceTPST
      Tempest Therapeutics Shares Surge 66.53% After Hours on CAR-T Deal - Tempest Therapeutics (NASDAQ:TPST)
      Sep 16BenzingaTPST
      12 Health Care Stocks Moving In Tuesday's After-Market Session
      Sep 15BenzingaGALTJUNSTPST
      Tempest Therapeutics stock surges on Senlang CAR-T deal
      Sep 15Investing.comTPST
      Tempest Therapeutics enters option deal for CAR-T platform
      Sep 15Investing.comTPST
      Tempest Therapeutics Gains Option to License New In-Body CAR-T Technology From Senlang

      Tempest Therapeutics (TPST) signed an exclusive option agreement with China's Hebei Senlang Biotechn

      Sep 15Yahoo FinanceTPST
      Tempest Therapeutics raises $2.5M in private placement
      Sep 11Investing.comTPST
      Tempest Therapeutics Announces Up to $7.5 Million Private Placement

      $2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrantsBRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,105,591

      Sep 11Yahoo FinanceTPST
      Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

      BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that Matt Angel, Ph.D., Tempest’s President and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026 at 2:30 p.m. ET. The webcast will be posted to Tempest’s w

      Sep 8Yahoo FinanceTPST

      This is the newest page. Registered accounts read further back.